메뉴 건너뛰기




Volumn 11, Issue 4, 2008, Pages 157-161

Anaemia following initiation of androgen deprivation therapy for metastatic prostate cancer: A retrospective chart review

Author keywords

Anaemia; Androgen deprivation therapy; Metastatic prostate cancer; Symptoms

Indexed keywords

BICALUTAMIDE; GOSERELIN; HEMOGLOBIN; LEUPRORELIN; ANILIDE; ANTIANDROGEN; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; NITRILE; TOLUENESULFONIC ACID DERIVATIVE;

EID: 63249123610     PISSN: 13685538     EISSN: 14730790     Source Type: Journal    
DOI: 10.1080/13685530802172438     Document Type: Article
Times cited : (14)

References (19)
  • 1
    • 84862809621 scopus 로고    scopus 로고
    • Available from:, Accessed 8 January 2006
    • American Cancer Society: Cancer Facts and Figures. Available from: http://www.cancer.org/downloads/STT/CAFF2006PW Secured.pdf. Accessed 8 January 2006.
    • Cancer Facts and Figures
  • 2
    • 0027984271 scopus 로고
    • A critique of the decision analysis for clinically localized prostate cancer
    • Beck JR, Kattan MV, Miles BJ. A critique of the decision analysis for clinically localized prostate cancer. J Urol 1994; 152:1894-1899.
    • (1994) J Urol , vol.152 , pp. 1894-1899
    • Beck, J.R.1    Kattan, M.V.2    Miles, B.J.3
  • 3
    • 0022405204 scopus 로고
    • Combination therapy with flutamide and castration (GNRH agonist or orchiectomy) in advanced prostate cancer: A marked improvement in response and survival
    • Labrie F, Dupont A, Belanger A, et al. Combination therapy with flutamide and castration (GNRH agonist or orchiectomy) in advanced prostate cancer: A marked improvement in response and survival. J Steroid Biochem 1985;123:833-841.
    • (1985) J Steroid Biochem , vol.123 , pp. 833-841
    • Labrie, F.1    Dupont, A.2    Belanger, A.3
  • 4
    • 0025102970 scopus 로고
    • Leuprolide with and without flutamide in advanced prostate cancer
    • Crawford ED, Blumenstein BA, Goodman PJ, et al. Leuprolide with and without flutamide in advanced prostate cancer. Cancer 1990;66:1039-1044.
    • (1990) Cancer , vol.66 , pp. 1039-1044
    • Crawford, E.D.1    Blumenstein, B.A.2    Goodman, P.J.3
  • 5
    • 0004315407 scopus 로고
    • A comparison of leuprolide and flutamide vs leuprolide alone in newly diagnosed stage D2 prostate cancer: Prognostic and therapeutic importance of the minimal disease subset
    • Eisenberger M, Crawford ED, McLeod D, et al. A comparison of leuprolide and flutamide vs leuprolide alone in newly diagnosed stage D2 prostate cancer: Prognostic and therapeutic importance of the minimal disease subset. Proc Am Soc Clin Oncol 1992;11:201.
    • (1992) Proc Am Soc Clin Oncol , vol.11 , pp. 201
    • Eisenberger, M.1    Crawford, E.D.2    McLeod, D.3
  • 6
    • 0042268032 scopus 로고    scopus 로고
    • The impact of androgen deprivation therapy on health related quality of life in asymptomatic men with lymph node positive prostate cancer
    • van Andel G, Kurth KH. The impact of androgen deprivation therapy on health related quality of life in asymptomatic men with lymph node positive prostate cancer. Eur Urol 2003; 44:209-214.
    • (2003) Eur Urol , vol.44 , pp. 209-214
    • van Andel, G.1    Kurth, K.H.2
  • 7
    • 0001525591 scopus 로고
    • Role of testicular secretions as indicated by effects of castration in man and by studies of pathological conditions and short lifespan associated with maleness
    • Hamilton JB. Role of testicular secretions as indicated by effects of castration in man and by studies of pathological conditions and short lifespan associated with maleness. Recent Prog Horm Res 1948;3:257-289.
    • (1948) Recent Prog Horm Res , vol.3 , pp. 257-289
    • Hamilton, J.B.1
  • 9
    • 0026102045 scopus 로고
    • Effect of reversible androgen deprivation on hemoglobin and serum immunoreactive erythropoietin in men
    • Weber JP, Walsh PC, Peters CA, Spivak JL. Effect of reversible androgen deprivation on hemoglobin and serum immunoreactive erythropoietin in men. Am J Hematol 1991;36:190-194.
    • (1991) Am J Hematol , vol.36 , pp. 190-194
    • Weber, J.P.1    Walsh, P.C.2    Peters, C.A.3    Spivak, J.L.4
  • 10
    • 0028214111 scopus 로고
    • Safety, side effects and patient acceptance of the luteinizing hormone releasing hormone agonist leuprolide in treatment of benign prostatic hyperplasia
    • Eri LM, Tveter KJ. Safety, side effects and patient acceptance of the luteinizing hormone releasing hormone agonist leuprolide in treatment of benign prostatic hyperplasia. J Urol 1994;152:448-452.
    • (1994) J Urol , vol.152 , pp. 448-452
    • Eri, L.M.1    Tveter, K.J.2
  • 11
    • 0000056463 scopus 로고
    • Anemia of androgen deprivation (AAD) in patients receiving combination hormone blockade: Response to erythropoietin
    • Strum SB, Tismag G. Anemia of androgen deprivation (AAD) in patients receiving combination hormone blockade: Response to erythropoietin. Proc Am Soc Clin Oncol 1994;13:238.
    • (1994) Proc Am Soc Clin Oncol , vol.13 , pp. 238
    • Strum, S.B.1    Tismag, G.2
  • 12
    • 0029909311 scopus 로고    scopus 로고
    • Development of anemia and recovery in prostate cancer patients treated with combined androgen blockade and radiotherapy
    • Asbell SO, Leon SA, Tester WJ, Brereton HD, et al. Development of anemia and recovery in prostate cancer patients treated with combined androgen blockade and radiotherapy. Prostate 1996;29:243-248.
    • (1996) Prostate , vol.29 , pp. 243-248
    • Asbell, S.O.1    Leon, S.A.2    Tester, W.J.3    Brereton, H.D.4
  • 13
    • 0033065107 scopus 로고    scopus 로고
    • Anaemia in men receiving combined finasteride and flutamide therapy for advanced prostate cancer
    • Ornstein DK, Beiser JA, Andriole GL. Anaemia in men receiving combined finasteride and flutamide therapy for advanced prostate cancer. BJU Int 1999;83:43-46.
    • (1999) BJU Int , vol.83 , pp. 43-46
    • Ornstein, D.K.1    Beiser, J.A.2    Andriole, G.L.3
  • 14
    • 0037525188 scopus 로고    scopus 로고
    • Combined androgen blockade-induced anemia in prostate cancer patients without bone involvement
    • Bogdanos J, Karamanolakis D, Milathianakis C, Repousis P, et al. Combined androgen blockade-induced anemia in prostate cancer patients without bone involvement. Anticancer Res 2003;23:1757-1762.
    • (2003) Anticancer Res , vol.23 , pp. 1757-1762
    • Bogdanos, J.1    Karamanolakis, D.2    Milathianakis, C.3    Repousis, P.4
  • 15
    • 10644250706 scopus 로고    scopus 로고
    • Anemia in patients on combined androgen block therapy for prostate cancer
    • Qian L, Hua L, Wu H, Sui Y, et al. Anemia in patients on combined androgen block therapy for prostate cancer. Asian J Androl 2004;6:383-384.
    • (2004) Asian J Androl , vol.6 , pp. 383-384
    • Qian, L.1    Hua, L.2    Wu, H.3    Sui, Y.4
  • 16
    • 20144363318 scopus 로고    scopus 로고
    • How are hemoglobin levels affected by androgen deprivation in nonmetastatic prostate cancer patients?
    • Choo R, Chander S, Danjoux C, Morton G, et al. How are hemoglobin levels affected by androgen deprivation in nonmetastatic prostate cancer patients? Can J Urol 2005;12: 2547-2552.
    • (2005) Can J Urol , vol.12 , pp. 2547-2552
    • Choo, R.1    Chander, S.2    Danjoux, C.3    Morton, G.4
  • 17
    • 0031400347 scopus 로고    scopus 로고
    • Anaemia associated with androgen deprivation in patients with prostate cancer receiving combined hormone blockade
    • Strum SB, McDermed JE, Scholz MC, Johnson H, et al. Anaemia associated with androgen deprivation in patients with prostate cancer receiving combined hormone blockade. Br J Urol 1997;79:933-941.
    • (1997) Br J Urol , vol.79 , pp. 933-941
    • Strum, S.B.1    McDermed, J.E.2    Scholz, M.C.3    Johnson, H.4
  • 18
    • 0034844689 scopus 로고    scopus 로고
    • Anemia related to hormonal ablation therapy for prostate cancer
    • Oh WK. Anemia related to hormonal ablation therapy for prostate cancer. The Prostate Journal 2001;3:14-17.
    • (2001) The Prostate Journal , vol.3 , pp. 14-17
    • Oh, W.K.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.